Aclarion, Inc. (ACONW)

Market Cap	4.27M
Revenue (ttm)	54,601
Net Income (ttm)	-6.70M
Shares Out	582.37K
EPS (ttm)	-11.50
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	27,180
Open	0.0362
Previous Close	0.0285
Day's Range	0.0245 - 0.0370
52-Week Range	0.0100 - 0.2446
Beta	1.21
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 7, 2025

About ACONW

Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam;...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2008
• Employees: 6
• Stock Exchange: NASDAQ
• Ticker Symbol: ACONW
• Website: https://www.aclarion.com

Financial Performance

In 2024, Aclarion's revenue was $45,724, a decrease of -39.36% compared to the previous year's $75,404. Losses were -$7.05 million, 43.6% more than in 2023.